title: Soluble intercellular adhesion molecule-1 levels of patients with acute myeloid leukemia after allogeneic bone marrow transplantation.
abstract: Concentrations of serum-soluble intercellular adhesion molecule-1 (ICAM-1) were measured for 10 patients with or without chronic graft versus host disease after allogeneic bone marrow transplantation. Levels of soluble ICAM-1 were higher among patients with chronic graft versus host disease than among those without it, a statistically significant difference. The results indicated that measurement of serum-soluble ICAM-1 is useful for prediction of chronic graft versus host disease.
authors.affiliation: Third Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Maeda
authors.forename: J
authors.initials: J
authors.lastname: Chihara
authors.forename: Y
authors.initials: Y
authors.lastname: Sumimoto
authors.forename: H
authors.initials: H
authors.lastname: Yamada
authors.forename: J
authors.initials: J
authors.lastname: Miyatake
authors.forename: M
authors.initials: M
authors.lastname: Matsuda
authors.forename: F
authors.initials: F
authors.lastname: Horiuchi
authors.forename: K
authors.initials: K
authors.lastname: Irimajiri
authors.forename: A
authors.initials: A
authors.lastname: Horiuchi
mesh_terms: D000208:Acute Disease; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006086:Graft vs Host Disease / Q000097:blood; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007951:Leukemia, Myeloid / Q000097:blood*; D012995:Solubility
chemical_list: D018799:Intercellular Adhesion Molecule-1